Article Details

Neuromyelitis Optica Spectrum Disorder Market Analysis Portrays a Promising Outlook of the ...

Retrieved on: 2021-05-11 03:45:00

Tags for this article:

Click the tags to see associated articles and topics

Neuromyelitis Optica Spectrum Disorder Market Analysis Portrays a Promising Outlook of the .... View article details on HISWAI: https://www.digitaljournal.com/pr/neuromyelitis-optica-spectrum-disorder-market-analysis-portrays-a-promising-outlook-of-the-emerging-drugs-during-the-forecast-period-2021-30

Excerpt

Emerging therapies in the NMOSD market include BAT4406F (Bio-Thera Solutions), CRD1 / cladribine (Chord Therapeutics), Ravulizumab (Alexion ...

Article found on: www.digitaljournal.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up